BENJAMIN F III MCGRAW
CIK 1216994 · Interim Executive Chair · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
24
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EVMN | Director | — | $19.83 | — | $0 | 1 | 2026-06-03 |
| AERIE PHARMACEUTICALS INC (AERI) Delisted | Interim Executive Chair | 0 | $15.25 | $0 | $0 | 12 | 2022-11-21 |
| ISTA PHARMACEUTICALS INC (ISTA) Delisted | Director | 3,966 | — | — | $0 | 6 | 2012-04-27 |
| Urigen Pharmaceuticals, Inc. (VLTS) Delisted | COB, President and CEO | 54,895 | — | — | $0 | 2 | 2007-04-30 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-10-15 | ISTA PHARMACEUTICALS INC (ISTA) Delisted | Grant (A) | +3,966 | $4 | EDGAR |
| 2007-07-02 | — | Tax (F) | −1,771 | -$283 | |
| 2007-04-30 | Urigen Pharmaceuticals, Inc. (VLTS) Delisted | Tax (F) | −2,657 | -$691 | EDGAR |
| 2007-01-31 | Urigen Pharmaceuticals, Inc. (VLTS) Delisted | Tax (F) | −3,162 | -$822 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.